Vice President, US Business Unit Lead, Rare Endocrinology and Rare Tumors

Lead the Rare Endocrinology and Rare Tumors business unit in the U.S., accountable for achieving revenue and patient acquisition goals. Drive commercial strategy and execution across in-country sales, marketing, and Thought-Leader Liaisons, while ensuring cross-functional alignment with Medical Affairs/HEOR, Market Access, Patient Services, and Business Operations. Build and manage teams, oversee a $1B+ P&L, develop in-country plans, launch pipeline assets, and use analytical business intelligence to optimize performance.